C WorldWide Group Holding A S Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

C WorldWide Group Holding A S reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 99,311 shares of the medical equipment provider's stock after selling 4,000 shares during the period. Intuitive Surgical makes up about 0.6% of C WorldWide Group Holding A S's holdings, making the stock its 21st biggest holding. C WorldWide Group Holding A S's holdings in Intuitive Surgical were worth $49,186,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Intuitive Surgical during the first quarter worth about $250,000. Commerzbank Aktiengesellschaft FI raised its stake in Intuitive Surgical by 15.4% during the first quarter. Commerzbank Aktiengesellschaft FI now owns 11,131 shares of the medical equipment provider's stock worth $5,513,000 after acquiring an additional 1,485 shares during the period. Asset Advisors Investment Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $1,707,000. Kingsview Wealth Management LLC raised its stake in Intuitive Surgical by 4.2% during the first quarter. Kingsview Wealth Management LLC now owns 4,535 shares of the medical equipment provider's stock worth $2,246,000 after acquiring an additional 181 shares during the period. Finally, Concord Wealth Partners raised its stake in Intuitive Surgical by 210.4% during the first quarter. Concord Wealth Partners now owns 3,390 shares of the medical equipment provider's stock worth $1,679,000 after acquiring an additional 2,298 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president directly owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ISRG. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Piper Sandler decreased their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Citigroup restated a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $592.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $1.61 during trading on Friday, reaching $514.56. The company had a trading volume of 411,060 shares, compared to its average volume of 1,679,570. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The stock has a market cap of $184.43 billion, a PE ratio of 75.54, a PEG ratio of 5.44 and a beta of 1.64. The business's 50 day moving average price is $536.26 and its 200-day moving average price is $536.13.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the firm posted $1.50 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.